By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cisbio will distribute Multispan's cell line portfolio in the US, under an agreement announced today by the firms.

The deal covers Multispan's cell line platform of more than 320 human and 209 rodent expression-ready cDNAs and 240 stable cell lines. The cell lines express G-protein coupled receptors in their native forms and "enable comprehensive investigation of effects of drug candidates on downstream signaling of each GPCR," the firms said in a joint statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.